3103 studies found for:    "Antifungal Agents"
Show Display Options
Rank Status Study
1 Active, not recruiting Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
Condition: Systemic Fungal Infections
Interventions: Drug: Parenteral micafungin application;   Drug: Other parenteral antifungal drugs
2 Completed Hygienic Socks With Antifungal Agent-loaded Microcapsules for Patients With Tinea Pedis
Condition: Tinea Pedis
Interventions: Drug: Anti-fungal agent (Clotrimazole) loaded microcapsules;   Drug: Placebo
3 Completed Antifungal Use in Oncohematological Neutropenic Patients
Condition: Invader Fungal Infection
Intervention: Drug: Antifungal drug. VORICONAZOL. (VFEND®)
4 Unknown  Antifungal Locks to Treat Fungal-Related Central Line Infections
Condition: Central Line Fungal Infections
Intervention: Drug: amphotericin B liposomal (Ambisome)
5 Unknown  Efficacy and Safety of RV4104A Ointment in Onychomycosis
Condition: Onychomycosis
Intervention: Drug: Keratolytic/Antifungal
6 Terminated Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer Patients
Conditions: Invasive Fungal Infections;   Invasive Aspergillosis;   Invasive Fusariosis
Intervention: Drug: caspofungin as preemptive antifungal therapy
7 Recruiting Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study (STAFE)
Conditions: Fungal Infection;   Critical Illness
Intervention: Other: Biomarker group
8 Terminated Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment
Conditions: Ventilator Associated Pneumonia;   Respiratory Tract Infection
Interventions: Other: Normal Saline;   Drug: anidulafungin
9 Recruiting International Pediatric Fungal Network
Condition: Pediatric Invasive Candidiasis
Intervention: Drug: Observational antifungal therapy
10 Completed Seifem Surveillance of Antifungal Combination Therapy In Hematologic Italian Centers
Condition: Fungal Infection
Intervention:
11 Unknown  Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis
Condition: Onychomycosis
Interventions: Drug: Amorolfine (Antifungal);   Drug: RV4104A, Ciclopiroxolamine, Cyclopirox (Keratolytic Agents/Antifungal)
12 Recruiting Empirical Versus Preemptive Antifungal Therapy
Conditions: Fungal Infection;   Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: caspofungin acetate
13 Recruiting A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis
Conditions: Immunocompromised;   Bone Marrow Transplant;   Cancer
Intervention: Drug: Micafungin
14 Terminated Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia
Conditions: Malignant Hemopathy;   Duration of Neutropenia Following Chemotherapy > 10 Days
Intervention: Drug: Amphotericin B
15 Completed
Has Results
β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients
Condition: Invasive Candidiasis
Interventions: Drug: Preemptive Therapy with Anidulafungin;   Drug: Empiric antifungal therapy based on physician discretion.
16 Terminated Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU
Condition: Invasive Fungal Infections
Interventions: Drug: Micafungin;   Drug: Placebo
17 Not yet recruiting Fluconazole Versus Micafungin in Neonates With Candidiasis
Condition: Candidiasis
Interventions: Drug: Fluconazole;   Drug: Micafungin
18 Not yet recruiting Laser Treatment for Onychomycosis in Diabetes
Conditions: Diabetes Mellitus, Type 2;   Onychomycosis
Interventions: Device: Laser Treatment YAG laser;   Drug: Standard Treatment (control group) terbinafine HCl
19 Completed PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-Cell Transplantation and Acute Leukaemia
Condition: Leukemia
Intervention: Drug: Ambisome
20 Completed PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation
Condition: Fungus Diseases
Intervention: Drug: AmBisome

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years